1013940-31-2Relevant articles and documents
THERAPEUTICALLY ACTIVE TRIAZOLES AND THEIR USE
-
Page/Page column 58; 59, (2008/06/13)
This invention relates to novel estratrien-triazoles of general formula (I) useful in therapy, especially for use in the treatment and/or prevention of a steroid hormone dependent disorder, preferably a steroid hormone dependent disease or disorder requiring the inhibition of a 17beta-hydroxysteroid dehydrogenase (17beta-HSD) such as 17beta-HSD type 1, type 2 or type 3 enzyme.